To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Reduced pain and disability over 26 weeks in patients treated with IA hyaluronan vs. sham

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
January 2016

Reduced pain and disability over 26 weeks in patients treated with IA hyaluronan vs. sham

Vol: 5| Issue: 1| Number:22| ISSN#: 2564-2537
Study Type:Randomized Trial
OE Level Evidence:2
Journal Level of Evidence:N/A

Viscosupplementation with hylan G-F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee

Clin Ther. 1998 May-Jun;20(3):410-23

Contributing Authors:
M Wobig A Dickhut R Maier G Vetter

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

110 patients (117 knees) with knee osteoarthritis were randomized to three weekly intra-articular injections of either hyaluronan (HA) (Hylan G-F 20) or saline. The purpose of this study was to evaluate and compare outcomes of pain and loss of activity between groups. Visual analog scales were used in the evaluation of patients over 26 weeks following the first injection. Results demonstrated sign...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue